Peyronie’s Disease Treatment: Xiaflex, PRP with Needling, Traction & Surgical Options

Penile Conditions — Peyronie’s Disease

Peyronie’s Disease Treatment: Xiaflex, PRP with Needling, Traction & Surgical Options

Peyronie’s disease causes fibrous scar tissue to form in the tunica albuginea, producing penile curvature, deformity, and in many cases painful erections. Treatment options range from non-invasive traction therapy to FDA-approved injectable collagenase — and for severe cases, surgical correction.

What Is Peyronie’s Disease?

Peyronie’s disease (PD) is a connective tissue disorder in which plaques — areas of hardened, inelastic scar tissue — form within the tunica albuginea, the fibrous sheath surrounding the corpora cavernosa. When an erection occurs, the inelastic plaque prevents full expansion in that region, causing the penis to bend, curve, narrow, or hinge toward the site of the plaque.

PD affects an estimated 3–9% of men, with prevalence increasing with age and in men with certain risk factors including Dupuytren’s contracture, Ledderhose disease, and trauma. Many cases arise from repetitive micro-injury during intercourse that the tunica fails to heal normally, triggering an overactive fibrotic response.

The disease progresses in two phases. The acute phase (typically 6–18 months from onset) involves active inflammation and plaque formation, often with pain during erection. The chronic phase is characterized by stable plaque and curvature; pain usually resolves but deformity remains. Treatment timing matters: interventions aimed at modifying the fibrotic process are most effective during or shortly after the acute phase.

Xiaflex (Collagenase Clostridium Histolyticum)

Xiaflex (CCH) is the only FDA-approved pharmacological treatment for Peyronie’s disease. It is a purified collagenase enzyme that, when injected directly into the plaque, breaks down the collagen fibers that make up the fibrous tissue. This softens and partially degrades the plaque, allowing modeling (manual straightening) to gradually improve curvature over a treatment course.

The standard treatment course involves up to 4 cycles, each consisting of two injections administered 1–3 days apart, followed by a modeling procedure by the patient at home over 6 weeks. Each cycle is separated by 6 weeks minimum. Clinical trials (the IMPRESS trials) showed a mean curvature reduction of approximately 17–34% and statistically significant improvements in patient-reported bother scores compared to placebo.

Who benefits most from Xiaflex: Men with stable (chronic-phase) Peyronie’s disease, curvature between 30–90 degrees, and a palpable plaque. Men with calcified plaques or very severe curvature (>90°) have shown less response. Xiaflex requires a physician trained in its administration and is contraindicated near the urethra or neurovascular bundle.

PRP with Plaque Needling

Platelet-rich plasma (PRP) injection combined with percutaneous needle fasciotomy (needling) of the plaque is an emerging approach with a growing clinical evidence base. The needling procedure uses a fine needle to mechanically disrupt the fibrotic plaque through multiple passes, breaking up collagen architecture. PRP — concentrated from the patient’s own blood — is injected into and around the disrupted plaque to deliver growth factors that may modulate the fibrotic healing response and promote tissue remodeling.

While not FDA-approved for PD specifically, multiple studies and clinical series have reported curvature reductions and improvements in penile length and sexual function following PRP with needling. The procedure is performed in office, typically under topical anesthesia, and can be repeated. It carries a favorable safety profile given the autologous nature of PRP.

PRP with needling is particularly attractive as an option in the acute phase, where active inflammation may be responsive to growth factor modulation, and for men who are not candidates for or who prefer to avoid Xiaflex.

Penile Traction Therapy

Penile traction devices (PTT) apply sustained mechanical force to the penis, stimulating tissue remodeling through mechanotransduction. For Peyronie’s disease, traction serves multiple purposes: it counteracts the shortening that PD causes, works against the contractile forces of the plaque, and may stimulate remodeling of the fibrotic tissue over time.

The European Association of Urology (EAU) includes PTT in its Peyronie’s disease guidelines. The RestoreX device, designed specifically for PD, was studied in a randomized trial that showed statistically significant reductions in curvature and improvements in stretched penile length after 3 months of daily use. PTT is recommended as an adjunct to Xiaflex treatment and as a standalone option, particularly for the penile length preservation component of PD management.

Surgical Treatment

Surgery is reserved for men with stable, chronic-phase Peyronie’s disease with curvature severe enough to prevent or significantly impair intercourse, who have not achieved adequate improvement with non-surgical treatment. Three main surgical approaches are used:

  • Plication: Sutures are placed on the opposite side of the curvature to shorten it and straighten the penis. The procedure is straightforward with a low complication rate but involves some penile shortening on the previously longer side.
  • Plaque incision or excision with grafting: The plaque is incised (scored) or excised and the resulting defect patched with a tissue graft. This approach preserves or restores length but carries a higher risk of erectile dysfunction post-operatively, particularly with excision.
  • Penile prosthesis with intraoperative modeling: For men who have both Peyronie’s disease and significant erectile dysfunction that doesn’t respond to medication, an inflatable penile prosthesis (IPP) is implanted. The prosthesis itself straightens the penis when inflated, and the surgeon can manually model (straighten) the erection intraoperatively to address residual curvature. This addresses both conditions simultaneously and is often the preferred option when ED coexists.

What to Expect

Non-surgical treatments require patience: meaningful curvature improvement with Xiaflex or traction develops over months. PD is a slow-moving condition, and treatment response is similarly gradual. Realistic expectations are essential — most men achieve meaningful improvement rather than complete resolution of curvature, and some degree of residual deformity often remains after non-surgical treatment.

Surgical outcomes are generally good in appropriately selected patients. Plication is predictable with a high patient satisfaction rate. Grafting procedures carry more variability. Prosthesis implantation, when both ED and PD are present, often produces excellent satisfaction scores in men who understand the trade-offs of prosthetic surgery.

Risks and Considerations

Xiaflex carries risks of penile hematoma (bruising), swelling, and in rare cases penile fracture if modeling is performed too aggressively. PRP and needling carry minimal risk given the autologous nature of the treatment and the precision of the procedure when performed by an experienced provider.

Surgical risks include the standard concerns for any urological surgery (infection, bleeding, anesthesia) plus procedure-specific risks: penile shortening with plication; ED with incision/grafting; device mechanical failure, infection, or revision surgery over time with prosthesis implantation.

All treatment decisions should be made in collaboration with a urologist or men’s health specialist with experience managing Peyronie’s disease. The optimal approach depends on disease phase, degree of curvature, plaque location, erectile function, and patient goals.

Speak With a Peyronie’s Disease Specialist

An experienced provider can evaluate your plaque, curvature, and erectile function to recommend the best treatment approach for your situation.

Find a Provider
Patient Reviews

Share Your Experience

Your review helps other patients make informed decisions about their care.

What Patients Are Saying

There are no reviews yet. Be the first one to write one.